UT/Erlanger Oncology & Hematology is a clinical research site located in Chattanooga, Tennessee, United States 37403.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
UT/Erlanger Oncology & Hematology has participated in 3 clinical trials.
Therapeutic areas: Clear Cell Renal Cell Carcinoma, Nonsmall Cell Lung Cancer, NSCLC.
Sponsors: Calithera Biosciences, Inc, NovoCure GmbH, NovoCure Ltd..
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UT/Erlanger Oncology & Hematology has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UT/Erlanger Oncology & Hematology has 3 clinical trials on record. Their work covers Clear Cell Renal Cell Carcinoma, Nonsmall Cell Lung Cancer, NSCLC.
UT/Erlanger Oncology & Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.